Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/22/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Martin S. Kleckner III

Wrong Martin S. Kleckner III?

Senior Vice President

RefluxMD Inc
10804 Willow Ct. B
San Diego , California 92127
United States

Company Description: RefluxMD delivers users authoritative, detailed, physician-approved information and even helps connect them with doctors in their area who specialize in reflux...   more

Employment History

  • Healthcare Executive
    RefluxMD Inc
  • Managing Principal
    La Costa Group LLC
  • Senior Vice President of Business Development
  • Founder and Chief Executive Officer
    U P Laboratories
  • Senior Vice President
    Respiratory Technology Corporation (Restech) / RefluxMD
  • Chief Operations Officer
  • Managing Principal
    Costa Group, LA
  • Senior Vice President for Business Development
  • Senior Vice President Business and Market Development
  • Division President
    LuminOre Healthcare
  • Chief Operations Officer
    The Nicholas Conor Institute for Pediatric Cancer Research , Inc.
  • Chief Operations and Business Development Officer
    The Nicholas Conor Institute for Pediatric Cancer Research , Inc.
  • Co-founder and Chief Business Officer and Co-founding Member
    Salvino-Flex LLC

Board Memberships and Affiliations


  • MBA
    University of California , Los Angeles
  • PhD , Public Policy
    University of California , Riverside
  • Bachelor of Arts ( BA , public policy and economics
    Whittier College
21 Total References
Web References
CureWize, 22 Feb 2015 [cached]
Dr. Martin S. Kleckner III, Senior VP for RefluxMD and Division President for LuminOre Healthcare Martin concentrates on business development, commercialization, capitalization and mentoring of life science start-up ventures including 501(3)c not-for-profit initiatives. His background comprises 26 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas. Martin served as the Chief Operations and Business Development Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc., specializing in the translation of new molecular biology (genomics and proteomics) diagnostics and treatments. He further provides commercialization advisory support to the National Institutes of Health, Drexel Foundation, Wallace H. Coulter Foundation, and Foresight Science & Technology with regard to “Go/No-Go†grant funding decisions and post-funding commercialization guidance.
Our Team | RefluxMD - Your guide to lifetime reflux relief, 15 July 2014 [cached]
Martin Kleckner
Martin Kleckner is a seasoned healthcare executive and entrepreneur with over 26 years of experience building technology firms and advising both start-up entities and large public companies. He is recognized for his expertise in business development, commercialization, capitalization and mentoring of healthcare start-up ventures. He has substantial experience guiding both emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia and the Americas. Mr. Kleckner earned his undergraduate degree from Whittier College, his master's in business administration from the University of California, Los Angeles, and a PhD in Public Policy from the University of California, Riverside.
FLEX PARTNERS, INC. - Bio's - Martin Kleckner, III - Director, Business Development, 21 Oct 2005 [cached]
Martin Kleckner
Martin Kleckner
solutions ... ideasBio's - Martin Kleckner, III - Director, Business Development
Mr. Kleckner has twenty four (24) years experience in strategic planning, business development, operations and financial management.His background comprises heavy experience in development and management of internal operations, corporate strategies, and conditions impacting company performances.
Mr. Kleckner is the founder of La Costa Group, LLC, a multi-partner consultancy based in Carlsbad, California where he has assisted over 65 companies, both emerging businesses and Fortune 100 corporations with new technology commercialization, capitalization, general management, strategic planning and business development.He has taught programs in sales & marketing, finance, and business economics throughout Europe, Asia and the Americas for several companies including General Electric, Honeywell, Allied Signal, Roche Diagnostics, Toshiba America Medical, AGFA, Fuji Medical, and Hewlett Packard.Before founding La Costa Group, he was Director of Venture Development & Contract Executive at American Healthcare Systems where he was responsible for medical device market growth alliances.At Times Mirror Cable Systems, he served senior positions in finance and marketing and was General Manager for a $17 million division where he had full profit and loss accountability with 155 employees, leading it as the highest financially performing division in 1985 & 1986.He is a former legislative advocate representing businesses in the California state legislature & Washington D.C.
Mr. Kleckner earned his MBA from the University of California, Los Angeles (UCLA), an MA in Public Policy from the University of California, Riverside, and holds a BA from Whittier College.He has completed all Ph.D. requirements except dissertation from the University of California and received a certificate in healthcare executive management from the University of California, San Diego.He is a frequent lecturer at national conferences and regularly contributes articles to medical industry journals.
TNCI Management, 14 June 2013 [cached]
Martin S. Kleckner III PhD MBA- Chief Operations Officer
Martin S. Kleckner III PhD MBA - Chief Operations Officer Martin has served in the life sciences industry for over twenty (20) years. Prior to TNCI, he was co-founder and Chief Executive Officer for U P Laboratories in San Diego for the production of proprietary patented synthetic peptides (Excitation Secretion Uncoupling Peptides - ESUP) as an alternative to botulinum neurotoxin (BoTox®) for topical anti-aging/wrinkle inhibition and hyperhidrosis. Earlier, he was Senior Vice President for Business Development at InSilicoMed, a start-up company providing bioengineering simulation tools for cardiology and ophthalmic therapy applications; Senior Vice President of Business Development for RegeneMed, a company creating three-dimensional (3D) liver tissue for drug discovery applications; Co-founder and Chief Business Officer/Co-founding member for Salvino-Flex LLC wherein he facilitated the research and development of a chest tube insertion device, eventually selling the company.
He also was Vice President of Development for Science and Engineering Associates for the research and commercialization of theranostics applications in cervical and ovarian cancer. Martin has further served as medical economist for Roche, Respironics, and Toshiba America plus was the co-founder/CEO of a counter-intelligence device which as showcased worldwide on BBC, NBC, ABC, CBS and Fox - receiving an 11-minute lead story, and then helped solve a crime in a 2004 episode of CSI Miami.
The International Group, Inc., 1 June 2009 [cached]
Martin Kleckner's work comprises a heavy emphasis on strategic planning, healthcare economics, cost & productivity, and business development for healthcare systems and corporations. He specializes in healthcare economics, strategic planning and execution, quality of care, clinical outcomes, hospital cost & productivity and business alliance management initiatives via six sigma process facilitation, focused studies and analytics; medical technology cost effectiveness & economic impact studies, work flows analyses, process mapping, sales and market development tools, operations management models. He guides healthcare corporations worldwide on the formation of effective business alliances with hospital systems and GPOs. Major current work comprises capital equipment planning, procurement & logistics for hospital design and development and the formation of healthcare system/university alliances for accelerated BSN and LPN-BSN programs.
Mr. Kleckner is a member of California's Tech Coast Angels concentrating on business development, capitalization and mentoring of life science start-up ventures. His background comprises 27 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas.
He is currently serving as investor, advisor and Business Development Officer for RegeneMed, specializing in 3-D engineering of human liver tissue for drug research & discovery and disease therapies. He is a co-founder of Salvino-Flex LLC, launching a cardio-thoracic device for emergency-trauma applications; and a co-founder with Source Atlantic, specializing in capital equipment planning, high volume procurement and logistics for new hospital construction world-wide. Earlier medical ventures include diagnostic and therapy approaches for oral, pharyngeal, cervical and ovarian cancers.
Previously he was Founder and CEO of a venture for counter-surveillance technology, receiving worldwide coverage by NBC, CBS, FOX, and the BBC.
Other People with the name "Kleckner":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.